US 11,851,424 B2
Solid forms of a modulator of hemoglobin
Stephan D. Parent, West LAfayette, IN (US); Travis Lee Houston, Lafayette, IN (US); Courtney S. Johnson, West Lafayette, IN (US); and Fang Wang, Foster City, CA (US)
Assigned to GLOBAL BLOOD THERAPEUTICS, INC., South San Francisco, CA (US)
Filed by Global Blood Therapeutics, Inc., South San Francisco, CA (US)
Filed on May 13, 2022, as Appl. No. 17/744,537.
Claims priority of provisional application 63/188,833, filed on May 14, 2021.
Prior Publication US 2022/0363674 A1, Nov. 17, 2022
Int. Cl. C07D 413/06 (2006.01)
CPC C07D 413/06 (2013.01) [C07B 2200/13 (2013.01)] 19 Claims
 
1. A crystalline Compound I Form I having the formula:

OG Complex Work Unit Chemistry
characterized by an X-ray powder diffractogram comprising diffraction peaks 10.8±0.2, 17.3±0.2, 17.5±0.2, 18.3±0.2, 23.4±0.2, 23.7±0.2, and 26.1±0.2 °2θ, as determined on a diffractometer using Cu-Kα radiation.